The cheapest way to get semaglutide
Ranked by published figure, labeled by gate. The cheapest number and the number you can actually get are usually two different routes.
As of August 31, 2026:
Ranked by the dollar figure each route publishes — which is not the same as ranked by what you will pay — the routes to semaglutide in August 2026 are: compounded semaglutide telehealth (verified from $88 per month month-to-month, or $139 true month-to-month); NovoCare self-pay ($349 per month for pens, verified; oral from $149). A commercial plan that covers Wegovy sits outside this ranking on purpose: Novo Nordisk publishes savings offers for covered patients, but no figure is recorded here because none would be true for a given reader — coverage and copays are plan-specific. A route’s published figure is a starting point, not a quote.
The routes, in order of the figure each one publishes
The order below is the published dollar figure, lowest first — and the first thing to know is that the figures are not like-for-like: the cheapest routes are gated by insurance or eligibility and carried here as reported, not verified. The verified routes are the ones this site exists to rank.
1. Compounded semaglutide telehealth
Verified from $88/mo on a plan; $139/mo month-to-month. The verified market: 12 first-party-verified providers, month-to-month range $88–$299 (median $178). Commitment rates and month-to-month rates are different purchases. Rankings: cheapest compounded semaglutide. Compounded semaglutide is not an FDA-approved product.
2. Brand-name Wegovy, self-pay via NovoCare
Verified $349/mo pens; $199 initial fills for qualifying new patients. Modeled year about $4,038. Oral form priced by dose. Detail: Wegovy self-pay price.
3. Commercial insurance that covers Wegovy + manufacturer savings offers
Unranked — no figure recorded here. Novo Nordisk publishes savings offers for commercially insured patients; we have not recorded them first-party and quote no number, because none would be true for a given reader. Coverage and copays are plan-specific.
Definitions used on this page
Questions this page answers
What is the cheapest way to get semaglutide?
Ranked by the dollar figure each route publishes — which is not the same as ranked by what you will pay — the routes to semaglutide in August 2026 are: compounded semaglutide telehealth (verified from $88 per month month-to-month, or $139 true month-to-month); NovoCare self-pay ($349 per month for pens, verified; oral from $149). A commercial plan that covers Wegovy sits outside this ranking on purpose: Novo Nordisk publishes savings offers for covered patients, but no figure is recorded here because none would be true for a given reader — coverage and copays are plan-specific. A route’s published figure is a starting point, not a quote.
Why are the insurance and Medicare figures labeled “reported”?
Because our verification standard is a first-party check of a purchasable published price, and copay programs are gated by coverage and eligibility that we cannot verify for any given reader. They are carried like grade-D rows: named, attributed, never counted as verified.